[Recording available] Immuno-oncology research workshop | Day 2

2023-02-01 | 07:00 AM - 10:00 AM (GMT+01:00) Paris


< Day 2 >

Program of the second day

15.00-15.45 Session 5

Lecture: Translating immune regulation into patient treatment in human diseases
Chair: Prof. Bruno QUESNEL
  • Prof. Daniel OLIVE

15.45-16.25 Session 6

Innovative clinical trials (with potential of Franco-Japanese collaboration)
Chair: Prof. Bruno QUESNEL
  • A Platform Study for Rare Cancers: MASTER KEY Project, Dr. Hitomi OKUMA, National Cancer Center
  • Precision Medicine in Pediatric Oncology - The Nationwide Pediatric Cancer Genome Profiling Project: JCCG-TOP2, Dr. Kayoko TAO, National Cancer Center

16.25-16.40 Break

16.40-17.25 Session 7

Innovative tools for cancer immunology (new analysis technologies, therapies and
Chair: Prof. Daniel OLIVE
  • Establishing a comprehensive analysis platform for immunogenomic analysis in the tumor microenvironment - Elucidation of mechanisms involved in immunotherapy resistance using clinical specimens, Dr. Shohei KOYAMA, National Cancer Center/ Osaka University
  • High-dimensional analysis of NK cell alterations in AML, Dr. Anne-Sophie CHRÉTIEN, Institut Paoli-Calmettes

17.25-18.40 Session 8

Translational and clinical applications
Chair: Prof Bruno Quesnel and Dr Hiroyuki Mano
  • Research and development of PRIME CAR-T cell therapy for solid cancers, Prof Koji TAMADA, Noile-Immune Biotech/Yamaguchi University
  • From immune targets to therapies, Prof. Daniel OLIVE, Imcheck Therapeutics
  • Harnessing of Natural Killer cells in Cancer Therapies & Presentation of the Paris Saclay Cancer Cluster (PSCC), Prof. Éric VIVIER, Centre d’Immunologie de Marseille Luminy/Innate Pharma/PSCC Association (on line)

18.40-18.55 Closing remarks

  • Dr. Hiroyuki MANO, Director - Research Institute, NCC
  • Prof. Bruno QUESNEL, Director - Research and Innovation Division, INCa